Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Product Information Update- Decapeptyl 3-month, 11.25 mg Powder and solvent for suspension for injection (Triptorelin)
Notice type:
3rd Party Publications
Date:
08/01/2016
Addition of a subcutaneous route of administration for male patients only to the existing marketing authorisation of intramuscular route.
Product name or type:
Decapeptyl 3-month, 11.25 mg Powder and solvent for suspension for injection (Triptorelin)
Authorisation Holder:
Ipsen Pharmaceuticals Ltd
Further Information:
PIU- Decapeptyl 3-month, 11.25 mg Powder and solvent for suspension for injection (Triptorelin)
« Back
Date Printed: 05/05/2024